Literature DB >> 6389806

Antigen-induced plaque-forming cell responses in cultures of peripheral blood mononuclear cells of human neonates and infants.

M J van Tol, J Zijlstra, B J Zegers, R E Ballieux.   

Abstract

Human cord blood mononuclear cells (CBMC) were stimulated in vitro with a number of T cell-dependent antigens. Antigen-induced B cell activation was measured applying a plaque-forming cell assay for the detection of antigen-specific IgM-secreting B cells. With the exception of diphtheria toxoid, the antigens ovalbumin, sheep red blood cells, Helix pomatia hemocyanin, burro red blood cells, and tetanus toxoid elicited an IgM-plaque-forming cell response in cultures of CBMC to levels obtained for peripheral blood mononuclear cells (PBMC) from adult controls. However, for each antigen used, the antigen dose optimal for the induction of a response was consistently found to be a hundred to a thousand times lower than the concentration of the corresponding antigen optimal for adult PBMC. Longitudinal studies on PBMC obtained from infants between 2 and 30 months of age revealed that a shift of the antigen dose toward concentrations needed to induce plaque-forming cells in cultures of adult PBMC occurs at approximately age 8 months. Our data indicate that various antigens can be used for the in vitro analysis of antigen-specific B cell activation and regulatory T cell functions in studies concerning the ontogeny of the humoral immune response in humans.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6389806     DOI: 10.1016/s0022-3476(84)80293-0

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  2 in total

1.  Expression and modulation of cell surface determinants on human adult and neonatal monocytes.

Authors:  P A Marwitz; E Van Arkel-Vigna; G T Rijkers; B J Zegers
Journal:  Clin Exp Immunol       Date:  1988-05       Impact factor: 4.330

2.  The antigen receptor complex on cord B lymphocytes.

Authors:  P J Macardle; H Weedon; M Fusco; S Nobbs; J Ridings; L Flego; D M Roberton; H Zola
Journal:  Immunology       Date:  1997-03       Impact factor: 7.397

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.